Deck 5 Bioproducts, Inc., a Delaware corporation, has perfected a new method of mass-producing and delivering viral reagents better, faster and less expensively to meet the needs of scientists conducting life sciences research.

We achieve this through implementation of a unique business process that combines several technical advances in the fields of molecular biology, virology, protein expression, purification and antibody production.

These advances enable us to deliver streamlined new product development and manufacturing, customer service and information technology. Our most significant differentiation from our competition is that Deck 5 will provide reagents that cover the entirety of the viral life cycle delivered in 24 hours.